Jacqueline Corrigan-Curay JD, MD U.S. FDA
Jacqueline Corrigan-Curay, JD, MD, is the Principal Deputy Center Director in the FDA’s Center for Drug Evaluation and Research (CDER) where she provides executive leadership on strategic initiatives that advance CDER's mission to deliver safe, effective and high-quality medications to the American public. Prior to taking on this role, Dr. Corrigan-Curay was the director of CDER’s Office of Medical Policy leading the development, coordination, and implementation of medical policy programs and strategic initiatives, including on real-world evidence, use of technology in drug development and prescription drug promotion .
Before joining FDA, she served as senior medical officer with the Immediate Office of the Director, National Heart, Lung and Blood Institute (NHLBI) at the National Institutes of Health (NIH). She also served as director of the Office of Biotechnology Activities (OBA), Office of Science Policy at NIH.
Dr. Corrigan-Curay earned her law degree from Harvard Law School, her medical degree from University of Maryland School of Medicine, and a bachelor’s degree in history of science from Harvard/Radcliffe College in Cambridge, MA.
Before joining FDA, she served as senior medical officer with the Immediate Office of the Director, National Heart, Lung and Blood Institute (NHLBI) at the National Institutes of Health (NIH). She also served as director of the Office of Biotechnology Activities (OBA), Office of Science Policy at NIH.
Dr. Corrigan-Curay earned her law degree from Harvard Law School, her medical degree from University of Maryland School of Medicine, and a bachelor’s degree in history of science from Harvard/Radcliffe College in Cambridge, MA.